Merkel cell carcinoma of the skin: A retrospective study of 24 cases by the Hellenic Cooperative Oncology Group

Oncology

Volumn 72, Issue 3-4, 2008, Pages 211-218

  Pectasides, D ^a   Papaxoinis, G ^a   Pectasides, E ^a,f   Galani, H ^b   Razi, E ^c   Katodrytis, N ^e   Fountzilas, G ^d   Economopoulos, T ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Henry Dunan Hospital   (Greece)

^c HYGEIA HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e Department of Medical Oncology ^*  (Cyprus)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adjuvant chemotherapy; Merkel cell carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MALE; MERKEL CELL TUMOR; METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38549109578     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112944     Document Type: Article

References (45)

1. Toker C: Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-110.
2. Hitchcock CL, Bland KI, Laney RG, Franzini D, Harris B, Copeland EM: Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988;207:201-207.
3. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG: Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23:2300-2309.
4. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW: Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001;8:204-208.
5. Pectasides D, Pectasides M, Economopoulos T: Merkel cell cancer of the skin. Ann Oncol 2006;17:1489-1495.
6. Goessling W, McKee PH, Mayer RJ: Merkel cell carcinoma. J Clin Oncol 2002;20:588-598.
7. Poulsen M: Merkel-cell carcinoma of the skin. Lancet Oncol 2004;5:593-599.
8. Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH: Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997;37:734-739.
9. Meeuwissen JA, Bourne RG, Kearsley JH: The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:325-331.
10. Pitale M, Sessions RB, Husain S: An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope 1992;102: 244-249.
11. Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A: The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80: 881-885.
12. Morrison WH, Peters LJ, Silva EG, Wendt CD, Ang KK, Goepfert H: The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990;19:583-591.
13. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS: Treatment of Merkel cell carcinoma. Am J Clin Oncol 2004;27:510-515.
14. Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P: Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685-690.
15. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH: A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113-117.
16. Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG: Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001;92: 1650-1655.
17. Hill AD, Mann GB, Borgen PI, Cody HS: Sentinel lymphatic mapping in breast cancer. J Am Coll Surg 1999;188:545-549.
18. Maza S, Trefzer U, Hofmann M, Schneider S, Voit C, Krossin T, Zander A, Audring H, Sterry W, Munz DL: Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging 2006;33:433-440.
19. O'Connor WJ, Roenigk RK, Brodland DG: Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997;23: 929-933.
20. O'Connor WJ, Brodland DG: Merkel cell carcinoma. Dermatol Surg 1996;22:262-267.
21. Cotlar AM, Gates JO Jr, Gibbs FA: Merkel cell carcinoma: combined surgery and radiation therapy. Am Surg 1986;52:159-164.
22. Wong KC, Zuletta F, Clarke SJ, Kennedy PJ: Clinical management and treatment outcomes of Merkel cell carcinoma. Aust N Z J Surg 1998;68:354-358.
23. Eich HT, Eich D, Staar S, Mauch C, Stutzer H, Groth W, Krieg T, Muller RP: Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol 2002;25:50-56.
24. Gillenwater AM, Hessel AC, Morrison WH, Burgess M, Silva EG, Roberts D, Goepfert H: Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149-154.
25. Muller A, Keus R, Neumann N, Lammering G, Schnabel T: Management of Merkel cell carcinoma: case series of 36 patients. Oncol Rep 2003;10:577-585.
26. Lewis KG, Weinstock MA, Weaver AL, Otley CC: Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006;142: 693-700.
27. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP: Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997;174:688-693.
28. Boyer JD, Zitelli JA, Brodland DG, D'Angelo G: Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002; 47:885-892.
29. Veness MJ, Perera L, McCourt J, Shannon J, Hughes TM, Morgan GJ, Gebski V: Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg 2005;75: 275-281.
30. Boyle F, Pendlebury S, Bell D: Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315-323.
31. King MM, Osswald MB: Adjuvant chemotherapy for Merkel cell carcinoma. Am J Clin Oncol 2005;28:634.
32. Pectasides D, Moutzourides G, Dimitriadis M, Varthalitis J, Athanassiou A: Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide. Am J Clin Oncol 1995;18: 418-420.
33. Pectasides D, Pectasides M, Psyrri A, Koumarianou A, Xiros N, Pectasides E, Gaglia A, Lianos E, Papaxoinis G, Lampadiari V, Economopoulos T: Cisplatin-based chemotherapy for Merkel cell carcinoma. Cancer Invest 2006;24:780-785.
34. Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, Gilchrist J: Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000;18:2493-2499.
35. Poulsen M, Rischin D, Walpole E, Harvey J, Mackintosh J, Ainslie J, Hamilton C, Keller J, Tripcony L, Trans-Tasman Radiation Oncology Group: High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study-TROG 96:07. J Clin Oncol 2003;21: 4371-4376.
36. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L: Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys 2006;64:114-119.
37. Fenig E, Lurie H, Klein B, Sulkes A: The treatment of advanced Merkel cell carcinoma: a multimodality chemotherapy and radiation therapy treatment approach. J Dermatol Surg Oncol 1993;19:860-864.
38. Fenig E, Lurie H, Sulkes A: The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol 1993;16:54-57.
39. Davis MP, Miller EM, Rau RC, Johnson OE, Naille RA, Crnkovich MJ: The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma. J Dermatol Surg Oncol 1990;16: 276-278.
40. Voog E, Biron P, Martin JP, Blay JY: Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589-2595.
41. Sharma D, Flora G, Grunberg SM: Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature. Am J Clin Oncol 1991;14:166-169.
42. Hanna N, Bunn PA Jr, Langer C, Einhorn L, Guthrie T Jr, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A: Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006;24:2038-2043.
43. Hasle H: Merkel cell carcinoma: the role of primary treatment with radiotherapy. Clin Oncol (R Coll Radiol) 1991;3:114-116.
44. Eng TY, Naguib M, Fuller CD, Jones WE 3rd, Herman TS: Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 2004;27:576-583.
45. Mortier L, Mirabel X, Fournier C, Piette F, Lartigau E: Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 2003; 139:1587-1590.